Navigation Links
HealthSouth Reports Strong Results for Third Quarter 2009 and Increases 2009 Guidance
Date:11/3/2009

' target='_blank' title='http://investor.healthsouth.com'>http://investor.healthsouth.com by clicking on an available link.

A replay of the conference call will be available, beginning approximately two hours after the completion of the conference call, from November 4 until November 18, 2009. To access the replay, please dial 8006421687. International callers should dial 7066459291. The webcast will also be archived for replay purposes after the live broadcast at http://investor.healthsouth.com.

About HealthSouth

HealthSouth is the nation's largest provider of inpatient rehabilitative healthcare services. Operating in 26 states across the country and in Puerto Rico, HealthSouth serves patients through its network of inpatient rehabilitation hospitals, long-term acute care hospitals, outpatient rehabilitation satellites, and home health agencies. HealthSouth strives to be the nation's preeminent provider of inpatient rehabilitative healthcare services and can be found on the Web at www.healthsouth.com.

Statements contained in this press release which are not historical facts are forward-looking statements. In addition, HealthSouth, through its senior management, may from time to time make forward-looking public statements concerning the matters described herein. All such estimates, projections, and forward-looking information speak only as of the date hereof, and HealthSouth undertakes no duty to publicly update or revise such forward-looking information, whether as a result of new information, future events, or otherwise. Such forward-looking statements are necessarily estimates based upon current information and involve a number of risks and uncertainties. HealthSouth's actual results may differ materially from the results anticipated in these forward-looking stat
'/>"/>

SOURCE HealthSouth Corporation
Copyright©2009 PR Newswire.
All rights reserved

1

GOOD

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22

Related medicine news :

1. HealthSouth Announces Date of 2009 Third Quarter Earnings Conference Call
2. HealthSouth Declares Dividend on 6.5% Series A Convertible Perpetual Preferred Stock
3. Wellmont, HealthSouth Form Joint Venture to Open a New Rehabilitation Hospital in Southwest Virginia
4. ATSU Arizona Health & Technology Park Partner HealthSouth Holds Grand Opening
5. HealthSouth Comments on Civil Litigation
6. HealthSouth Declares Dividend on 6.5% Series A Convertible Perpetual Preferred Stock
7. HealthSouth Announces Date of 2009 Second Quarter Earnings Conference Call
8. Court Rules in Favor of HealthSouth in Litigation Involving General Medicine, P.C.
9. HealthSouth to Present at 34th Annual Deutsche Bank Health Care Conference
10. HealthSouth Reports Strong EPS Results for First Quarter Ended March 31, 2009
11. HealthSouth to Present at Bairds 2009 Growth Stock Conference
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/16/2009)... myopia now than in the ,70s, study finds , , ... more common in the United States than it was ... study shows. , Researchers compared National Health and Nutrition ... from 1971 to 1972 and from 8,339 black and ... 12 to 54 years old. , The prevalence of ...
(Date:12/16/2009)... earn a free 21-count one week trial bottle sample with purchase ... ... December 16, 2009 -- ImmuneResponse247.com announces a special ... Immune Response 247™ 6 Mushroom Formula , with the purchase ... 247™ 6 Mushroom Formula is packaged in FDA approved facilities and ...
(Date:12/16/2009)... proud to announce being presented with the Weatherhead 100 Upstart Award ... growing companies in Northeast Ohio and is a testament to hard ... , ... (PRWEB) December 16, 2009 -- Request A ... 100 Upstart Award on December 3, 2009. The Weatherhead 100 ...
(Date:12/16/2009)... the perfect gift to give that special woman who has everything? ... Esthetician Mary Schook introduces exceptional beauty products online while educating the ... ... (PRWEB) December 16, 2009 -- The holidays are rapidly ... special woman who has everything? Why stem cells, of course!, , ...
(Date:12/15/2009)... SUMMARY: The U.S. Senate today rejected ... Care Act that would have helped make prescription ... and legal importation of lower priced drugs from ... sponsored by Senators Dorgan, Snowe, McCain, Grassley and ... bring down the skyrocketing costs of prescription drugs. ...
Breaking Medicine News(10 mins):Health News:Free Sample of Proven Health Mushroom Supplement Offered By ImmuneResponse247.com 2Health News:Free Sample of Proven Health Mushroom Supplement Offered By ImmuneResponse247.com 3Health News:Free Sample of Proven Health Mushroom Supplement Offered By ImmuneResponse247.com 4Health News:Request A Test Receives Weatherhead 100 Upstart Award 2Health News:New Online Beauty Store Suggests Stem Cells for the Woman Who Has Everything 2Health News:AARP Disappointed By Senate Vote Against Lower Prescription Drug Prices 2Health News:AARP Disappointed By Senate Vote Against Lower Prescription Drug Prices 3
... to the issue of self harm. Self-Harm is most often ... support, help and above all, understanding. According to a recent ... to help a person who self-harms. ,The "see ... to the fore - that nearly 41% of adults ...
... has now established that a delayed-release stimulant, used for ... with less abuse, when compared to other stimulant drugs//. ... an oral formulation have not been reported to produce ... results of the study can be found in the ...
... is a major cause of depression and Alzheimer's disease in ... which shrinks in old age resulting in depression and Alzheimer's ... develop new treatments for Alzheimer’s disease. ,The shrinkage ... cortex result in the release of high levels of stress ...
... Paris: The French government is bracing itself to tackle a ... called the Chikungunya Fever, known to be spread by mosquitoes// ... poses a risk of entering into France. ,According ... infected one fifth of La Reunion's population , and many ...
... P's and Q's, trim your hair, cut your nails, polish your ... women, no gaudy saris please //-- just some of the do's ... visit. ,Tips on how to look and what to ... prime minister and visiting dignitaries along with the special protection group ...
... has commended India for the alacrity with which the ... in the country in the last fortnight. // ... They have told us the quick response of the ... Husbandry) Upma Chowdhury informed reporters. "India's actions have added ...
Other Medicine News:Health News:Concerta, Drug Used in ADHD Treatment Less Likely To Result In Abuse 2Health News:Mind your looks for Bush visit, as world is watching 2
(Date:12/15/2009)... ZURICH, Ill., Dec. 15 Fenwal Inc., a ... availability for patient care, reiterated its commitment to provide ... lifesaving blood products, despite a new lawsuit filed yesterday ... Fenwal® Alyx® system, introduced in 2003, is an advanced ... red cells from a single donor in about 30 ...
(Date:12/15/2009)... -- PDL BioPharma, Inc. (PDL) (Nasdaq: PDLI ) ... 2009 special dividend payment of $1.67 per share to ... 1, 2009. With this payment, distributions to stockholders ... per share. In January 2010, the Company will ... the Company,s 2009 cash distributions and the allocation between ...
(Date:12/15/2009)... Champions Biotechnology, Inc . (OTC ... development of advanced preclinical platforms and tumor specific ... today announced its financial results for the second ... details of Company,s financial results are available in ... ,, Total revenues for the second quarter of ...
Breaking Medicine Technology:Fenwal Responds to New Lawsuit From Haemonetics; Reiterates Commitment to Blood Centers 2Fenwal Responds to New Lawsuit From Haemonetics; Reiterates Commitment to Blood Centers 3PDL BioPharma Completes December 15 Special Dividend Payment 2Champions Biotechnology Reports Fiscal 2010 Second Quarter Financial Results 2Champions Biotechnology Reports Fiscal 2010 Second Quarter Financial Results 3Champions Biotechnology Reports Fiscal 2010 Second Quarter Financial Results 4Champions Biotechnology Reports Fiscal 2010 Second Quarter Financial Results 5Cepheid Receives FDA Clearance for First On Demand Molecular Diagnostic Test for Clostridium difficile Infection 51429 1Cepheid Receives FDA Clearance for First On Demand Molecular Diagnostic Test for Clostridium difficile Infection 51429 2Cepheid Receives FDA Clearance for First On Demand Molecular Diagnostic Test for Clostridium difficile Infection 51429 3Cepheid Receives FDA Clearance for First On Demand Molecular Diagnostic Test for Clostridium difficile Infection 51429 4Cepheid Receives FDA Clearance for First On Demand Molecular Diagnostic Test for Clostridium difficile Infection 51429 5Spots Still Available to Run 2009 ING New York City Marathon With Team Reeve 51427 1Spots Still Available to Run 2009 ING New York City Marathon With Team Reeve 51427 2Fruitfly Model of a Neuropathic Disease Demonstrates Novel Role for Proteins in the Family of aTyr Pharmas Product Class 4717 1Fruitfly Model of a Neuropathic Disease Demonstrates Novel Role for Proteins in the Family of aTyr Pharmas Product Class 4717 2Fruitfly Model of a Neuropathic Disease Demonstrates Novel Role for Proteins in the Family of aTyr Pharmas Product Class 4717 3
... -, PHOENIX, Sept. 4 Zila, Inc.,s (Nasdaq: ... early detection of,abnormalities which can lead to oral cancer, ... II study of Cetuximab (ERBITUX(R)), a,leading cancer therapeutic for ... IMCL ) and distributed by Bristol-Meyers Squibb (NYSE:,BMY). ...
... Monte Carlo brings predictability to whole range ... of Phase II, III and ... Tourtellotte Solutions, a,global leader in off-the-shelf and custom supply ... today announced,the release of its tcVisualize(TM) 3.0 clinical trial ...
Other Medicine Technology:Zila Inc. Product Selected to Identify Pre-Cancer in Study of Leading Cancer Treatment Chemotherapeutic - ERBITUX 2Zila Inc. Product Selected to Identify Pre-Cancer in Study of Leading Cancer Treatment Chemotherapeutic - ERBITUX 3Tourtellotte Solutions Blazes Trail with New Release of Clinical Trial Supply Chain Simulator 2
... ARUP Laboratories is a national reference laboratory ... research and development. ARUP offers an extensive ... medical tests in clinical and anatomic pathology. ... Laboratories' clients include more than half of ...
... ARUP Laboratories is a national reference laboratory ... research and development. ARUP offers an extensive ... medical tests in clinical and anatomic pathology. ... Laboratories' clients include more than half of ...
... reference laboratory and a worldwide leader in ... an extensive test menu of highly complex ... anatomic pathology. Owned by the University of ... half of the nation's university teaching hospitals ...
... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
Medicine Products: